Form 8-K - Current report:
SEC Accession No. 0001004878-13-000363
Filing Date
2013-12-19
Accepted
2013-12-19 17:28:00
Documents
6
Period of Report
2013-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K LAIDLAW AGREEMENT form8klaidlawagree12-13.txt 8-K 8635
2 EXH. 1.1 UNDERWRITING AGREEMEMT form8klaidlawagreeexh1112-13.txt EX-1 196327
3 EXH. 5 OPINION OF HART & HART, LLC form8klaidlawagreeexh512-13.txt EX-5 3660
4 EXH. 23 CONSENT OF HART & HART, LLC form8klaidlawagreeexh2312-13.txt EX-23 864
5 EXH. 99.1 PRESS RELEASE form8klaidlawexh991dec-13.txt EX-99 4611
6 EXH. 99.2 PRESS RELEASE form8klaidlawexh992dec-13.txt EX-99 5508
  Complete submission text file 0001004878-13-000363.txt   220860
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 131289135
SIC: 2836 Biological Products, (No Diagnostic Substances)